CD40LG and autoimmune polyendocrinopathy: The 2023 ACR/EULAR APS classification criteria included an entry criterion of at least one positive aPL test within 3 years of identification of an aPL-associated clinical criterion, followed by additive weighted criteria (score range 1–7 points each) clustered into 6 clinical domains and 2 laboratory domains (lupus anticoagulant functional coagulation assays, and ELISA for IgG/IgM anticardiolipin and/or IgG/IgM anti–β2-glycoprotein-1 antibodies).